title: From efficacy to impact: an advocate's agenda for HIV pre-exposure prophylaxis implementation.
authors.affiliation: AVAC: Global Advocacy for HIV Prevention, New York, New York 10027, USA. mitchell@avac.org
authors.forename: Mitchell J
authors.initials: MJ
authors.lastname: Warren
authors.forename: Emily S
authors.initials: ES
authors.lastname: Bass
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage*; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004338:Drug Combinations; D000069480:Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D015658:HIV Infections / Q000517:prevention & control*; D006284:Health Plan Implementation; D006801:Humans; D009943:Organophosphorus Compounds / Q000008:administration & dosage*; D011322:Primary Prevention
chemical_list: D019380:Anti-HIV Agents; D004338:Drug Combinations; D000069480:Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D009943:Organophosphorus Compounds; D003841:Deoxycytidine